George Grigoriadis

2.2k total citations
62 papers, 978 citations indexed

About

George Grigoriadis is a scholar working on Hematology, Molecular Biology and Immunology. According to data from OpenAlex, George Grigoriadis has authored 62 papers receiving a total of 978 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Hematology, 19 papers in Molecular Biology and 16 papers in Immunology. Recurrent topics in George Grigoriadis's work include Multiple Myeloma Research and Treatments (10 papers), Immune Cell Function and Interaction (9 papers) and Lymphoma Diagnosis and Treatment (9 papers). George Grigoriadis is often cited by papers focused on Multiple Myeloma Research and Treatments (10 papers), Immune Cell Function and Interaction (9 papers) and Lymphoma Diagnosis and Treatment (9 papers). George Grigoriadis collaborates with scholars based in Australia, United States and Canada. George Grigoriadis's co-authors include Alastair G. Stewart, Ashish Banerjee, Steve Gerondakis, Ajithkumar Vasanthakumar, Michael Löw, Raelene J. Grumont, Pasquale L. Fedele, Raffi Gugasyan, Trudi Harris and Simon N. Willis and has published in prestigious journals such as The Journal of Experimental Medicine, SHILAP Revista de lepidopterología and The EMBO Journal.

In The Last Decade

George Grigoriadis

60 papers receiving 963 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
George Grigoriadis Australia 19 305 284 276 186 151 62 978
Anja Vales Austria 20 338 1.1× 282 1.0× 433 1.6× 91 0.5× 115 0.8× 30 1.0k
Robert E. Ettlinger United States 8 394 1.3× 367 1.3× 238 0.9× 222 1.2× 85 0.6× 8 1.5k
Jiro Yamana Japan 14 449 1.5× 143 0.5× 417 1.5× 153 0.8× 101 0.7× 17 1.0k
Toshiyuki Bohgaki Japan 21 260 0.9× 243 0.9× 449 1.6× 177 1.0× 72 0.5× 65 1.2k
Sofie Starckx Belgium 14 189 0.6× 165 0.6× 222 0.8× 146 0.8× 228 1.5× 19 789
Zhimin Zhai China 16 287 0.9× 393 1.4× 217 0.8× 160 0.9× 48 0.3× 49 910
David Bastian United States 20 591 1.9× 380 1.3× 295 1.1× 164 0.9× 94 0.6× 42 1.0k
Hideaki Fujiwara Japan 17 286 0.9× 214 0.8× 275 1.0× 223 1.2× 44 0.3× 71 909
Sara Ture United States 16 267 0.9× 340 1.2× 252 0.9× 112 0.6× 56 0.4× 35 925
Bakul I. Dalal Canada 19 276 0.9× 261 0.9× 317 1.1× 209 1.1× 41 0.3× 51 1.1k

Countries citing papers authored by George Grigoriadis

Since Specialization
Citations

This map shows the geographic impact of George Grigoriadis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by George Grigoriadis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites George Grigoriadis more than expected).

Fields of papers citing papers by George Grigoriadis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by George Grigoriadis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by George Grigoriadis. The network helps show where George Grigoriadis may publish in the future.

Co-authorship network of co-authors of George Grigoriadis

This figure shows the co-authorship network connecting the top 25 collaborators of George Grigoriadis. A scholar is included among the top collaborators of George Grigoriadis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with George Grigoriadis. George Grigoriadis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Grigoriadis, George, Shaun Fleming, Pasquale L. Fedele, et al.. (2025). Ratifying the efficacy and safety of intensive induction chemotherapy for acute myeloid leukaemia by the Australasian Leukaemia & Lymphoma Group consensus approach. Internal Medicine Journal. 55(5). 749–759.
2.
Παππάς, Νικόλαος, et al.. (2024). Nasal Septum Perforation Repair: Simplicity and low Morbidity Using the Temporalis Fascia and Silicone Films. Indian Journal of Otolaryngology and Head & Neck Surgery. 76(6). 5409–5413. 1 indexed citations
3.
Fedele, Pasquale L., Yang Liao, Jianan Gong, et al.. (2020). The transcription factor IRF4 represses proapoptotic BMF and BIM to licence multiple myeloma survival. Leukemia. 35(7). 2114–2118. 21 indexed citations
4.
Teh, Charis E., Jianan Gong, David Segal, et al.. (2020). Deep profiling of apoptotic pathways with mass cytometry identifies a synergistic drug combination for killing myeloma cells. Cell Death and Differentiation. 27(7). 2217–2233. 25 indexed citations
5.
Löw, Michael, Pasquale L. Fedele, Anna Kalff, et al.. (2018). DCEP as a bridge to ongoing therapies for advanced relapsed and/or refractory multiple myeloma. Leukemia & lymphoma. 59(12). 2842–2846. 12 indexed citations
6.
Narayan, Nisha, Melissa Chen, Maarten Fornerod, et al.. (2017). Microrna-211 - a Novel Oncogene in Acute Myeloid Leukemia. Blood. 130. 2507. 1 indexed citations
7.
Cummins, Katherine D., Glen Westall, & George Grigoriadis. (2015). Numerous Howell‐Jolly bodies in a patient with idiopathic splenic calcification. British Journal of Haematology. 169(6). 767–767. 1 indexed citations
8.
Cummins, Katherine D., et al.. (2015). PAX5-expressing ALK-negative anaplastic large cell lymphoma with extensive extranodal and nodal involvement. BMJ Case Reports. 2015. bcr2015211159–bcr2015211159. 11 indexed citations
9.
Banerjee, Ashish, Nicole A. Mifsud, Robert Bird, et al.. (2014). The oral iron chelator deferasirox inhibits NF‐κB mediated gene expression without impacting on proximal activation: implications for myelodysplasia and aplastic anaemia. British Journal of Haematology. 168(4). 576–582. 26 indexed citations
10.
Ling, Victoria, et al.. (2014). A dimorphic blast population demonstrates Philadelphia-positive mixed phenotype acute leukaemia. Pathology. 46(3). 244–246. 1 indexed citations
11.
Grigoriadis, George, Lorraine A. O’Reilly, Simon N. Willis, et al.. (2014). 65. Cytokine. 70(1). 43–43. 1 indexed citations
12.
Sidwell, Tom, et al.. (2013). Thymic Regulatory T Cell Development: Role of Signalling Pathways and Transcription Factors. SHILAP Revista de lepidopterología. 2013. 1–8. 15 indexed citations
13.
Lancaster, Graeme I., Greg M. Kowalski, Emma Estévez, et al.. (2012). Tumor Progression Locus 2 (Tpl2) Deficiency Does Not Protect against Obesity-Induced Metabolic Disease. PLoS ONE. 7(6). e39100–e39100. 16 indexed citations
14.
Gerondakis, Steve, Ashish Banerjee, George Grigoriadis, et al.. (2012). NF‐κB subunit specificity in hemopoiesis. Immunological Reviews. 246(1). 272–285. 45 indexed citations
15.
Al‐Tamimi, Mohammad, George Grigoriadis, Huy Tran, et al.. (2011). Coagulation-induced shedding of platelet glycoprotein VI mediated by factor Xa. Blood. 117(14). 3912–3920. 67 indexed citations
16.
Gugasyan, Raffi, Sarah Kinkel, George Grigoriadis, et al.. (2011). The NF‐κB1 transcription factor prevents the intrathymic development of CD8 T cells with memory properties. The EMBO Journal. 31(3). 692–706. 18 indexed citations
18.
Stewart, Alastair G., George Grigoriadis, & Trudi Harris. (1994). MITOGENIC ACTIONS OF ENDOTHELIN‐1 AND EPIDERMAL GROWTH FACTOR IN CULTURED AIRWAY SMOOTH MUSCLE. Clinical and Experimental Pharmacology and Physiology. 21(4). 277–285. 46 indexed citations
19.
Grigoriadis, George & Alastair G. Stewart. (1992). Albumin inhibits platelet‐activating factor (PAF)‐induced responses in platelets and macrophages: implications for the biologically active form of PAF. British Journal of Pharmacology. 107(1). 73–77. 36 indexed citations
20.
Stewart, Alastair G. & George Grigoriadis. (1991). Structure-activity relationships for platelet-activating factor (PAF) and analogues reveal differences between PAF receptors on platelets and macrophages.. PubMed. 4(3). 299–308. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026